Reassessing the Link: Depression and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: Insights From the ACCORD-HRQL Study.

Συγγραφείς: Yi D; Department of Cardiac Surgery, Extracorporeal Life Support Center of Cardiovascular Surgery, Second Xiangya Hospital, Central South University, Changsha, China., Xing Z; Department of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China.; Emergency Medicine and Difficult Diseases Institute, Central South University, Changsha 410011, China.

Πηγή: Depression and anxiety [Depress Anxiety] 2025 May 05; Vol. 2025, pp. 1885956. Date of Electronic Publication: 2025 May 05 (Print Publication: 2025).

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Wiley Country of Publication: United States NLM ID: 9708816 Publication Model: eCollection Cited Medium: Internet ISSN: 1520-6394 (Electronic) Linking ISSN: 10914269 NLM ISO Abbreviation: Depress Anxiety Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Diabetes Mellitus, Type 2*/epidemiology , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/psychology , Diabetic Nephropathies*/epidemiology , Diabetic Nephropathies*/physiopathology , Depression*/epidemiology , Quality of Life*/psychology , Depressive Disorder*/epidemiology, Humans ; Male ; Female ; Middle Aged ; Aged ; Albuminuria/epidemiology ; Disease Progression ; Glomerular Filtration Rate ; Comorbidity ; Prospective Studies

Cross Talk Between Macrophages and Podocytes in Diabetic Nephropathy: Potential Mechanisms and Novel Therapeutics.

Συγγραφείς: Yu S; Department of Nephrology II, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150036, China., Han Z; First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China., Li C; First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China., Lu X; First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China., Li Y; First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China., Yuan X; First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China.; Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin 150006, China., Guo D; Department of Cardiology, Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150001, China.

Πηγή: Mediators of inflammation [Mediators Inflamm] 2025 May 02; Vol. 2025, pp. 8140479. Date of Electronic Publication: 2025 May 02 (Print Publication: 2025).

Τύπος έκδοσης: Journal Article; Review

Στοιχεία περιοδικού: Publisher: Wiley Country of Publication: United States NLM ID: 9209001 Publication Model: eCollection Cited Medium: Internet ISSN: 1466-1861 (Electronic) Linking ISSN: 09629351 NLM ISO Abbreviation: Mediators Inflamm Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Podocytes*/metabolism , Diabetic Nephropathies*/metabolism , Diabetic Nephropathies*/immunology , Macrophages*/metabolism, Humans ; Animals ; Apoptosis/physiology ; Autophagy/physiology

Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction.

Συγγραφείς: Vranken NPA; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Li X; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Bouman H; Division of Nephrology, Department of Internal Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Mourmans SGJ; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Achten A; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Barandiarán Aizpurua A; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Brunner-La Rocca HP; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Knackstedt C; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202 AZ, Maastricht, The Netherlands., van Empel VPM; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Weerts J; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202 AZ, Maastricht, The Netherlands. jerremy.weerts@mumc.nl.

Πηγή: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Apr 05; Vol. 24 (1), pp. 156. Date of Electronic Publication: 2025 Apr 05.

Τύπος έκδοσης: Journal Article; Observational Study

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Heart Failure*/physiopathology , Heart Failure*/diagnosis , Heart Failure*/mortality , Heart Failure*/epidemiology , Heart Failure*/therapy , Albuminuria*/diagnosis , Albuminuria*/epidemiology , Albuminuria*/mortality , Albuminuria*/physiopathology , Albuminuria*/therapy , Stroke Volume* , Ventricular Function, Left* , Diabetes Mellitus*/diagnosis , Diabetes Mellitus*/mortality , Diabetes Mellitus*/epidemiology , Diabetic Nephropathies*/diagnosis , Diabetic Nephropathies*/mortality , Diabetic Nephropathies*/epidemiology , Diabetic Nephropathies*/therapy , Diabetic Nephropathies*/physiopathology, Humans ; Female ; Male ; Aged ; Prevalence ; Prognosis ; Time Factors ; Risk Factors ; Risk Assessment ; Aged, 80 and over ; Biomarkers/blood ; Blood Glucose/metabolism ; Retrospective Studies ; Hospitalization ; Comorbidity ; Middle Aged

Targeting NLRP3 and AIM2 signaling pathways by Viscosol alleviates metabolic dysregulations induced inflammatory responses in diabetic neuro- and nephropathy: An in silico and in vivo study.

Συγγραφείς: Thahiem S; Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan., Ihsan M; Department of Biosciences, COMSATS University Islamabad, Tarlai Kalan, Islamabad, Pakistan., Muneer H; Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.; Department of Biochemistry & Biotechnology, MNS University of Agriculture Multan, Multan, Pakistan., Sohail A; Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan., Khan M; Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan., Murtaza I; Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan., Uddin Z; Department of Pharmacy, COMSATS University Islamabad, Abbottabad, KP, Pakistan., Shafique M; Department of Pharmacology, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia., Alzahrani KJ; Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia., Ali H; Department of Biosciences, COMSATS University Islamabad, Tarlai Kalan, Islamabad, Pakistan., Ullah I; Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

Πηγή: PloS one [PLoS One] 2025 Apr 02; Vol. 20 (4), pp. e0313816. Date of Electronic Publication: 2025 Apr 02 (Print Publication: 2025).

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Ιατρικοί όροι (MeSH): NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein*/genetics , Signal Transduction*/drug effects , Diabetic Nephropathies*/metabolism , Diabetic Nephropathies*/drug therapy , Diabetic Nephropathies*/pathology , DNA-Binding Proteins*/metabolism , Diabetes Mellitus, Experimental*/drug therapy , Diabetes Mellitus, Experimental*/metabolism, Animals ; Male ; Mice ; Mice, Inbred C57BL ; Inflammasomes/metabolism ; Inflammation/drug therapy ; Inflammation/metabolism ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/metabolism ; Protein Tyrosine Phosphatase, Non-Receptor Type 1/antagonists & inhibitors ; Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism ; Kidney/drug effects ; Kidney/pathology ; Kidney/metabolism ; Molecular Docking Simulation

Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease.

Συγγραφείς: Felício JS; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil. felicio.bel@terra.com.br., Araújo MAM; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., de Lemos GN; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., Fernandes IJ; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., Ruivo LO; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., Chambouleyron EDG; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., de Souza D'Albuquerque Silva L; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., Nunes CF; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., de Andrade Paes GM; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., de Melo FTC; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., Piani PPF; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., Motta ARB; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., Leal VSG; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., de Souza ACCB; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., de Queiroz NNM; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., Dos Santos MC; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., Felício KM; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil., de Figueiredo PAB; University Hospital João de Barros Barreto, Endocrinology Division, Federal University of Pará, Mundurucus Street, Guamá, Belém, 4487, 66073-000, Pará, Brazil.

Πηγή: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Mar 28; Vol. 24 (1), pp. 144. Date of Electronic Publication: 2025 Mar 28.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/physiopathology , Heart Rate* , Diabetic Neuropathies*/diagnosis , Diabetic Neuropathies*/physiopathology , Diabetic Neuropathies*/etiology , Diabetic Nephropathies*/diagnosis , Diabetic Nephropathies*/physiopathology , Diabetic Nephropathies*/etiology , Autonomic Nervous System*/physiopathology , Autonomic Nervous System Diseases*/diagnosis , Autonomic Nervous System Diseases*/physiopathology , Autonomic Nervous System Diseases*/etiology, Humans ; Male ; Cross-Sectional Studies ; Female ; Middle Aged ; Aged ; Predictive Value of Tests ; Reproducibility of Results ; Albuminuria/diagnosis ; Albuminuria/physiopathology ; Albuminuria/etiology ; Severity of Illness Index

A SuperLearner approach for predicting diabetic kidney disease upon the initial diagnosis of T2DM in hospital.

Συγγραφείς: Lin X; Ningbo Institute of Chinese Medicine Research, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, No. 819, Liyuan North Road, Haishu District, Ningbo, 315010, China., Liu C; Yidu Cloud Technology Inc., Beijing, 100083, China.; Nanjing YiGenCloud Institute, Nanjing, 211899, China., Wang H; National Institute of Traditional Chinese Medicine Constitution and Preventive Treatment of Diseases, Beijing University of Chinese Medicine, Beijing, 100029, China., Fan X; Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Li L; Yidu Cloud Technology Inc., Beijing, 100083, China., Xu J; Yidu Cloud Technology Inc., Beijing, 100083, China., Li C; Department of Nephrology, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, 315010, China., Wang Y; Yidu Cloud Technology Inc., Beijing, 100083, China., Cai X; Department of Nephrology, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, 315010, China., Peng X; Ningbo Institute of Chinese Medicine Research, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, No. 819, Liyuan North Road, Haishu District, Ningbo, 315010, China. pengx@nit.zju.edu.cn.

Πηγή: BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2025 Mar 26; Vol. 25 (1), pp. 148. Date of Electronic Publication: 2025 Mar 26.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101088682 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6947 (Electronic) Linking ISSN: 14726947 NLM ISO Abbreviation: BMC Med Inform Decis Mak Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/complications , Diabetic Nephropathies*/diagnosis , Diabetic Nephropathies*/etiology, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult

Potential benefits of GLP-1 receptor agonist in dialysis patients with type 2 diabetes: the need for comprehensive pharmacokinetic and hemodialysis analyses.

Συγγραφείς: Lai HW; School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan., Chen JY; Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Centre, Tainan, Taiwan.; Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan., Wu VC; Division of Nephrology, Primary Aldosteronism Centre of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; NSARF (National Taiwan University Hospital Study Group of ARF), and CAKS (Consortium for Acute Kidney Injury and Renal Diseases), Taipei, Taiwan., See CY; Division of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University , Tainan, Taiwan. seechunyin99@gmail.com.

Πηγή: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Mar 08; Vol. 24 (1), pp. 110. Date of Electronic Publication: 2025 Mar 08.

Τύπος έκδοσης: Journal Article; Letter; Comment

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/blood , Glucagon-Like Peptide-1 Receptor Agonists* , Renal Dialysis*/adverse effects , Renal Insufficiency, Chronic*/diagnosis , Renal Insufficiency, Chronic*/therapy , Renal Insufficiency, Chronic*/blood , Blood Glucose*/metabolism , Blood Glucose*/drug effects , Diabetic Nephropathies*/diagnosis , Diabetic Nephropathies*/therapy , Diabetic Nephropathies*/blood , Incretins*/pharmacokinetics , Incretins*/adverse effects , Incretins*/therapeutic use , Glycemic Control*/adverse effects , Hypoglycemic Agents*/pharmacokinetics , Hypoglycemic Agents*/adverse effects , Hypoglycemic Agents*/therapeutic use, Humans ; Treatment Outcome ; Biomarkers/blood ; Male ; Female ; Middle Aged ; Aged ; Glucagon-Like Peptide-1 Receptor

Long-term trajectory of estimated glomerular filtration rate in ambulatory patients with type 2 diabetes and heart failure: clinical insights and prognostic implications.

Συγγραφείς: Julián MT; Department of Endocrinology and Nutrition and Heart Failure Clinic, Hospital Germans Trias i Pujol, Badalona, Spain., Codina P; Heart Failure Clinic and Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Carretera del Canyet s/n, 08916, Barcelona, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain., Lupón J; Heart Failure Clinic and Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Carretera del Canyet s/n, 08916, Barcelona, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain., Zamora E; Heart Failure Clinic and Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Carretera del Canyet s/n, 08916, Barcelona, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain., Pérez-Montes de Oca A; Department of Endocrinology and Nutrition and Heart Failure Clinic, Hospital Germans Trias i Pujol, Badalona, Spain., Domingo M; Heart Failure Clinic and Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Santiago-Vacas E; Heart Failure Clinic and Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Borrellas A; Heart Failure Clinic and Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Ruiz-Cueto M; Heart Failure Clinic and Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain., González-Gallego C; Department of Endocrinology and Nutrition and Heart Failure Clinic, Hospital Germans Trias i Pujol, Badalona, Spain., Troya M; Heart Failure Clinic and Nephrology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Romero-González GA; Heart Failure Clinic and Nephrology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Alonso N; Department of Endocrinology and Nutrition and Heart Failure Clinic, Hospital Germans Trias i Pujol, Badalona, Spain. nalonso32416@yahoo.es.; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Carretera del Canyet s/n, 08916, Barcelona, Spain. nalonso32416@yahoo.es.; Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. nalonso32416@yahoo.es., Bayes-Genis A; Heart Failure Clinic and Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain. abayesgenis@gmail.com.; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Carretera del Canyet s/n, 08916, Barcelona, Spain. abayesgenis@gmail.com.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain. abayesgenis@gmail.com.

Πηγή: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Mar 05; Vol. 24 (1), pp. 104. Date of Electronic Publication: 2025 Mar 05.

Τύπος έκδοσης: Journal Article; Observational Study

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Glomerular Filtration Rate* , Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/mortality , Diabetes Mellitus, Type 2*/physiopathology , Heart Failure*/mortality , Heart Failure*/physiopathology , Heart Failure*/diagnosis , Kidney*/physiopathology , Diabetic Nephropathies*/physiopathology , Diabetic Nephropathies*/diagnosis , Diabetic Nephropathies*/mortality, Humans ; Male ; Female ; Aged ; Middle Aged ; Time Factors ; Prospective Studies ; Registries ; Risk Factors ; Biomarkers/blood ; Prognosis ; Disease Progression ; Risk Assessment ; Aged, 80 and over

Management of Diabetes in Patients with Chronic Kidney Disease.

Συγγραφείς: Ambalavanan J; Department of Endocrinology and Metabolism, Institute of Clinical Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Caramori ML; Department of Endocrinology and Metabolism, Institute of Clinical Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, USA.; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

Πηγή: Endocrine research [Endocr Res] 2025 May; Vol. 50 (2), pp. 65-75. Date of Electronic Publication: 2025 Mar 21.

Τύπος έκδοσης: Journal Article; Review

Στοιχεία περιοδικού: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8408548 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4206 (Electronic) Linking ISSN: 07435800 NLM ISO Abbreviation: Endocr Res Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Renal Insufficiency, Chronic*/therapy , Renal Insufficiency, Chronic*/complications , Diabetes Mellitus*/therapy , Diabetic Nephropathies*/therapy, Humans ; Cardiovascular Diseases/prevention & control ; Life Style

Association between cardiac metabolic index and diabetic kidney disease: a cross-sectional study of NHANES 1999-2018.

Συγγραφείς: Zhang L; School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China., Liang C; Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China., Yan Z; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Li Q; Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China. 88375326@qq.com.

Πηγή: Journal of health, population, and nutrition [J Health Popul Nutr] 2025 Apr 03; Vol. 44 (1), pp. 105. Date of Electronic Publication: 2025 Apr 03.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: Bangladesh NLM ID: 100959228 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-1315 (Electronic) Linking ISSN: 16060997 NLM ISO Abbreviation: J Health Popul Nutr Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Diabetic Nephropathies*/epidemiology, Humans ; Male ; Cross-Sectional Studies ; Female ; Nutrition Surveys ; Middle Aged ; Adult ; United States/epidemiology ; Aged ; Prevalence

The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study.

Συγγραφείς: Agur T; Department of Nephrology and Hypertension, Rabin Medical Center, Ze'ev Jabotinsky St 39, Petah Tikva, Israel. Timna.Agur@clalit.org.il.; Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel. Timna.Agur@clalit.org.il., Steinmetz T; Department of Nephrology and Hypertension, Rabin Medical Center, Ze'ev Jabotinsky St 39, Petah Tikva, Israel.; Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Goldman S; Department of Nephrology and Hypertension, Rabin Medical Center, Ze'ev Jabotinsky St 39, Petah Tikva, Israel.; Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Zingerman B; Department of Nephrology and Hypertension, Rabin Medical Center, Ze'ev Jabotinsky St 39, Petah Tikva, Israel.; Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Bielopolski D; Department of Nephrology and Hypertension, Rabin Medical Center, Ze'ev Jabotinsky St 39, Petah Tikva, Israel.; Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Nesher E; Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.; Department of Transplantation, Rabin Medical Center, Petah Tikva, Israel., Fattal I; Department of Nephrology and Hypertension, Rabin Medical Center, Ze'ev Jabotinsky St 39, Petah Tikva, Israel.; Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Meisel E; Department of Nephrology and Hypertension, Rabin Medical Center, Ze'ev Jabotinsky St 39, Petah Tikva, Israel.; Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Rozen-Zvi B; Department of Nephrology and Hypertension, Rabin Medical Center, Ze'ev Jabotinsky St 39, Petah Tikva, Israel.; Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.

Πηγή: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Feb 28; Vol. 24 (1), pp. 97. Date of Electronic Publication: 2025 Feb 28.

Τύπος έκδοσης: Journal Article; Observational Study; Comparative Study

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Metformin*/therapeutic use , Metformin*/adverse effects , Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Sodium-Glucose Transporter 2 Inhibitors*/adverse effects , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/mortality , Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/blood , Diabetic Nephropathies*/mortality , Diabetic Nephropathies*/diagnosis , Diabetic Nephropathies*/prevention & control , Diabetic Nephropathies*/physiopathology , Kidney*/physiopathology , Kidney*/drug effects , Blood Glucose*/drug effects , Blood Glucose*/metabolism , Kidney Failure, Chronic*/mortality , Kidney Failure, Chronic*/diagnosis , Kidney Failure, Chronic*/prevention & control, Humans ; Male ; Retrospective Studies ; Female ; Disease Progression ; Middle Aged ; Aged ; Treatment Outcome ; Risk Factors ; Time Factors ; Risk Assessment ; Biomarkers/blood ; Drug Therapy, Combination ; Glomerular Filtration Rate/drug effects ; Protective Factors ; Databases, Factual

Cellular crosstalk in organotypic vasculature: mechanisms of diabetic cardiorenal complications and SGLT2i responses.

Συγγραφείς: Wang W; National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China., Liu Y; The Second Department of Geriatrics, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100091, China.; Key Laboratory of Disease and Syndrome Integration Prevention and Treatment of Vascular Aging, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China., Xu Q; National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China., Liu L; National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China., Zhu M; National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China., Li Y; National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China., Cui J; National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China., Chen K; National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China., Liu Y; National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China. liuyueheart@hotmail.com.; The Second Department of Geriatrics, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100091, China. liuyueheart@hotmail.com.; Key Laboratory of Disease and Syndrome Integration Prevention and Treatment of Vascular Aging, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China. liuyueheart@hotmail.com.

Πηγή: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Feb 26; Vol. 24 (1), pp. 90. Date of Electronic Publication: 2025 Feb 26.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Endothelial Cells*/metabolism , Endothelial Cells*/drug effects , Endothelial Cells*/pathology , Cell Communication*/drug effects , Sodium-Glucose Transporter 2 Inhibitors*/pharmacology , Diabetic Nephropathies*/metabolism , Diabetic Nephropathies*/pathology , Diabetic Nephropathies*/drug therapy , Kidney*/metabolism , Kidney*/blood supply , Kidney*/drug effects , Kidney*/pathology , Diabetic Angiopathies*/metabolism , Diabetic Angiopathies*/pathology , Diabetic Angiopathies*/drug therapy, Animals ; Signal Transduction ; Single-Cell Analysis ; Humans ; Mice

Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients.

Συγγραφείς: Lin LC; Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chen JY; Division of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.; Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan., Huang TT; Division of Nephrology, Primary Aldosteronism Center of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; NSARF (National Taiwan University Hospital Study Group of ARF), and CAKS (Taiwan Consortium for Acute Kidney Injury and Renal Diseases), Taipei, Taiwan., Wu VC; Division of Nephrology, Primary Aldosteronism Center of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. q91421028@ntu.edu.tw.; NSARF (National Taiwan University Hospital Study Group of ARF), and CAKS (Taiwan Consortium for Acute Kidney Injury and Renal Diseases), Taipei, Taiwan. q91421028@ntu.edu.tw.; Department of Internal Medicine, National Taiwan University Hospital, Room 1555, B4, Clinical Research Building, 7 Chung-Shan South Road, Taipei, 100, Taiwan. q91421028@ntu.edu.tw.

Πηγή: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Feb 21; Vol. 24 (1), pp. 87. Date of Electronic Publication: 2025 Feb 21.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/mortality , Diabetes Mellitus, Type 2*/diagnosis , Glucagon-Like Peptide-1 Receptor Agonists* , Kidney Transplantation*/adverse effects , Kidney Transplantation*/mortality , Cardiovascular Diseases*/mortality , Cardiovascular Diseases*/prevention & control , Cardiovascular Diseases*/diagnosis , Incretins*/adverse effects , Incretins*/therapeutic use , Hypoglycemic Agents*/adverse effects , Hypoglycemic Agents*/therapeutic use , Diabetic Nephropathies*/mortality , Diabetic Nephropathies*/diagnosis, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Aged ; Time Factors ; Risk Assessment ; Risk Factors ; Adult ; Databases, Factual ; Glucagon-Like Peptide-1 Receptor

Proteomic and metabolomic profiling reveals the underlying molecular mechanisms in modified alternate-day fasting-mediated protection against Diabetic kidney disease.

Συγγραφείς: Zeng X; Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China., Xing YH; Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China., Ma XM; Sichuan Provincial Key Laboratory for Human Disease Gene Study and Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China., Long Y; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Sichuan, People's Republic of China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, People's Republic of China., Jiang ZZ; Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Sichuan, People's Republic of China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, People's Republic of China., Xu Y; Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Sichuan, People's Republic of China.; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, People's Republic of China.

Πηγή: PloS one [PLoS One] 2025 Feb 18; Vol. 20 (2), pp. e0319053. Date of Electronic Publication: 2025 Feb 18 (Print Publication: 2025).

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Diabetic Nephropathies*/metabolism , Diabetic Nephropathies*/prevention & control , Diabetic Nephropathies*/pathology , Proteomics* , Fasting*/metabolism , Metabolomics* , Metabolome* , Proteome*/metabolism, Animals ; Mice ; Male ; Kidney/metabolism ; Kidney/pathology ; Diet, High-Fat/adverse effects ; Mice, Inbred C57BL ; Blood Glucose/metabolism

Prevalence and determinants of poor glycemic control among diabetic chronic kidney disease patients on maintenance hemodialysis in Tanzania.

Συγγραφείς: Mfundo EA; Quality Assurance Department, National Health Insurance Fund, Arusha, Tanzania.; Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Marealle AI; Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Nyondo GG; Department of Medicinal Chemistry, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Manguzu MA; Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Buma D; Department of Clinical Research, Training and Consultancy, Muhimbili National Hospital, Dar es Salaam, Tanzania., Kunambi P; Department of Clinical Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Mutagonda RF; Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Πηγή: PloS one [PLoS One] 2025 Feb 10; Vol. 20 (2), pp. e0306357. Date of Electronic Publication: 2025 Feb 10 (Print Publication: 2025).

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Renal Dialysis* , Glycemic Control* , Renal Insufficiency, Chronic*/therapy , Renal Insufficiency, Chronic*/blood , Renal Insufficiency, Chronic*/epidemiology , Diabetic Nephropathies*/therapy , Diabetic Nephropathies*/epidemiology , Diabetic Nephropathies*/blood, Humans ; Tanzania/epidemiology ; Female ; Male ; Middle Aged ; Glycated Hemoglobin/analysis ; Glycated Hemoglobin/metabolism ; Prevalence ; Cross-Sectional Studies ; Adult ; Aged ; Blood Glucose/analysis ; Hypoglycemic Agents/therapeutic use

The association between stress-induced hyperglycemia ratio and cardiovascular events as well as all-cause mortality in patients with chronic kidney disease and diabetic nephropathy.

Συγγραφείς: Cao B; Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China., Guo Z; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Li DT; Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China., Zhao LY; Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China., Wang Z; Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China. zhenwangdzm@126.com., Gao YB; Department of Nephropathy, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China. 1020061312@qq.com., Wang YX; Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China. tcmwyx123@126.com.; Department of Nephropathy, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China. tcmwyx123@126.com.

Πηγή: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Feb 06; Vol. 24 (1), pp. 55. Date of Electronic Publication: 2025 Feb 06.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Hyperglycemia*/mortality , Hyperglycemia*/diagnosis , Hyperglycemia*/blood , Cardiovascular Diseases*/mortality , Cardiovascular Diseases*/diagnosis , Cardiovascular Diseases*/blood , Renal Insufficiency, Chronic*/mortality , Renal Insufficiency, Chronic*/diagnosis , Renal Insufficiency, Chronic*/blood , Blood Glucose*/metabolism , Diabetic Nephropathies*/mortality , Diabetic Nephropathies*/diagnosis , Diabetic Nephropathies*/blood , Stress, Physiological*, Humans ; Female ; Male ; Middle Aged ; Aged ; Biomarkers/blood ; Risk Assessment ; United States/epidemiology ; Nutrition Surveys ; Prognosis ; Risk Factors ; Cause of Death ; Time Factors ; Adult ; Incidence ; Predictive Value of Tests ; Cross-Sectional Studies ; Heart Disease Risk Factors

The urinary microbiome in association with diabetes and diabetic kidney disease: A systematic review.

Συγγραφείς: Graells T; Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institute, Huddinge, Stockholm, Sweden., Lin YT; Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institute, Huddinge, Stockholm, Sweden.; Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan., Ahmad S; Molecular Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.; Preventive Medicine Division, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Natural Sciences, Technology and Environmental Studies, Södertörn University, Huddinge, Sweden., Fall T; Molecular Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Ärnlöv J; Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institute, Huddinge, Stockholm, Sweden.; Center for Clinical Research Dalarna, Uppsala University, Falun, Sweden.; School of Health and Welfare, Dalarna University, Falun, Sweden.

Πηγή: PloS one [PLoS One] 2025 Jan 31; Vol. 20 (1), pp. e0317960. Date of Electronic Publication: 2025 Jan 31 (Print Publication: 2025).

Τύπος έκδοσης: Journal Article; Systematic Review

Στοιχεία περιοδικού: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Microbiota* , Diabetic Nephropathies*/microbiology , Diabetic Nephropathies*/urine , Diabetes Mellitus, Type 2*/microbiology , Diabetes Mellitus, Type 2*/urine, Humans ; Female ; Male ; Cross-Sectional Studies ; Case-Control Studies

Chlorogenic acid inhibits NLRP3 inflammasome activation through Nrf2 activation in diabetic nephropathy.

Συγγραφείς: Bao L; Department of Nephrology, Pu'er People's Hospital, Pu'er, Yunnan, China., Gong Y; Department of Nephrology, Pu'er People's Hospital, Pu'er, Yunnan, China., Xu W; Department of Gastrointestinal and Plastic Surgery, Pu'er People's Hospital, Pu'er, Yunnan, China., Dao J; Department of Nephrology, Pu'er People's Hospital, Pu'er, Yunnan, China., Rao J; Department of Nephrology, Pu'er People's Hospital, Pu'er, Yunnan, China., Yang H; Department of Nephrology, Pu'er People's Hospital, Pu'er, Yunnan, China.

Πηγή: PloS one [PLoS One] 2025 Jan 06; Vol. 20 (1), pp. e0316615. Date of Electronic Publication: 2025 Jan 06 (Print Publication: 2025).

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Chlorogenic Acid*/pharmacology , Chlorogenic Acid*/therapeutic use , Diabetic Nephropathies*/drug therapy , Diabetic Nephropathies*/metabolism , Diabetic Nephropathies*/pathology , NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism , NF-E2-Related Factor 2*/metabolism , Inflammasomes*/metabolism, Animals ; Rats ; Male ; Diabetes Mellitus, Experimental/drug therapy ; Diabetes Mellitus, Experimental/metabolism ; Diabetes Mellitus, Experimental/complications ; Rats, Sprague-Dawley ; Oxidative Stress/drug effects ; Signal Transduction/drug effects

Genetic predisposition to nephropathy and associated cardiovascular disease in people with type 1 diabetes: role of the angiotensinI-converting enzyme (ACE), and beyond; a narrative review.

Συγγραφείς: Mohammedi K; INSERM U1034, Biology of Cardiovascular Diseases, Bordeaux University Hospital, 33000, Bordeaux, France. km.mmohammedi@gmail.com.; Department of Endocrinology, Diabetes, and Nutrition, Hôpital Haut-Lévêque, Avenue de Magellan, 33604, Pessac Cedex, France. km.mmohammedi@gmail.com., Marre M; Clinique Ambroise Paré. Diabétologie-Endocrinologie, 92200, Neuilly-Sur-Seine, France.; Immunity and Metabolism in Diabetes, Institut Necker Enfants Malades, INSERM U1151, CNRS UMR 8253, Paris, France., Alhenc-Gelas F; INSERMU1138-Centre de Recherche Des Cordeliers, Paris Cite University, Sorbonne University, 75006, Paris, France.

Πηγή: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Dec 21; Vol. 23 (1), pp. 453. Date of Electronic Publication: 2024 Dec 21.

Τύπος έκδοσης: Journal Article; Review

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Genetic Predisposition to Disease* , Diabetic Nephropathies*/genetics , Diabetic Nephropathies*/diagnosis , Diabetic Nephropathies*/enzymology , Diabetes Mellitus, Type 1*/genetics , Diabetes Mellitus, Type 1*/diagnosis , Diabetes Mellitus, Type 1*/complications , Diabetes Mellitus, Type 1*/enzymology , Peptidyl-Dipeptidase A*/genetics , Cardiovascular Diseases*/genetics , Cardiovascular Diseases*/diagnosis , Cardiovascular Diseases*/enzymology , Cardiovascular Diseases*/epidemiology, Humans ; Phenotype ; Genome-Wide Association Study ; Risk Factors ; Polymorphism, Genetic

GLP-1RA improves diabetic renal injury by alleviating glomerular endothelial cells pyrotosis via RXRα/circ8411/miR-23a-5p/ABCA1 pathway.

Συγγραφείς: Wu W; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China., Wang Y; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China., Shao X; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China., Huang S; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China., Wang J; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China., Zhou S; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China., Liu H; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China., Lin Y; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China., Yu P; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China.

Πηγή: PloS one [PLoS One] 2024 Dec 02; Vol. 19 (12), pp. e0314628. Date of Electronic Publication: 2024 Dec 02 (Print Publication: 2024).

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Ιατρικοί όροι (MeSH): MicroRNAs*/genetics , MicroRNAs*/metabolism , Diabetic Nephropathies*/metabolism , Diabetic Nephropathies*/pathology , Diabetic Nephropathies*/drug therapy , Diabetic Nephropathies*/genetics , RNA, Circular*/genetics , ATP Binding Cassette Transporter 1*/metabolism , ATP Binding Cassette Transporter 1*/genetics , Endothelial Cells*/metabolism , Endothelial Cells*/drug effects , Mice, Inbred C57BL* , Pyroptosis*/drug effects, Animals ; Mice ; Retinoid X Receptor alpha/metabolism ; Retinoid X Receptor alpha/genetics ; Glucagon-Like Peptide-1 Receptor/metabolism ; Glucagon-Like Peptide-1 Receptor/genetics ; Kidney Glomerulus/pathology ; Kidney Glomerulus/metabolism ; Kidney Glomerulus/drug effects ; Diabetes Mellitus, Experimental/metabolism ; Cholesterol/metabolism ; Male ; Signal Transduction/drug effects